Thursday, February 21, 2019

MixedTimes - CNBC

'Young blood' company Ambrosia halts patient treatments after FDA warning

A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss, NBC News reports.

Garmin forecasts higher full-year revenue, shares rise

Garmin reported quarterly results that beat Wall Street estimates on Wednesday on the back of higher demand for its smartwatches and navigation systems and forecast full-year revenue above expectations.

Electric-plane start-up gets propulsion boost from Siemens

German industrial conglomerate Siemens is eyeing electric flight in deal to make propulsion systems for electric-plane start-up Eviation. The start-up wants to bring battery-powered flight to short-haul trips.

CVS shares drop on mixed results, disappointing forecast

CVS Health reported mixed fourth-quarter results, and issued a forecast that fell short of Wall Street's expectations. The company closed its $70 billion acquisition of health insurer Aetna in November.

Amazon isn't killing Walmart online

Walmart's latest earnings report shows the largest bricks-and-mortar retailer in the world is making progress in building out its website, despite Amazon's looming presence.

Sign Up for Our Newsletter

Get breaking news and thought-provoking commentary
directly mailed to your inbox, faster than AIR MAIL!

Get Informed

Sign up for breaking news and thought-provoking commentary delivered directly to your inbox.